Germany: CJEU requirements in FRAND cases

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Germany: CJEU requirements in FRAND cases

For years, the courts have been preoccupied with infringement proceedings that are conducted by standard essential patents (SEP) holders, who previously submitted declarations as part of the standardization process, namely assurances that prospective licensees will be granted licences under fair, reasonable and non-discriminatory (FRAND) conditions. The dispute is particularly about the extent to which an SEP can be enforced in court by dominant companies without them, in doing so, breaching the antitrust abuse law under Article 102 TFEU.

In its judgment Huawei Technologies / ZTE from July 16 2015 (Rn C-170/13), the CJEU showed how patent holders and patent infringers should behave in infringement proceedings concerning a SEP with a FRAND declaration, to avoid committing an antitrust infringement and thereby be able to rely on the antitrust compulsory licence objection (proprietor) and not to risk a sentence for the omission of further acts of use (patent infringer):

Although, through the submission of a FRAND declaration, the patentee does not waive the judicial assertion of injunctive relief or recall claims, he does, however, create a legitimate expectation to that effect, on the basis of which he is obliged to point out to patent infringers their alleged infringement before bringing an action for injunction or recall and to hear their case. If the infringer expresses his willingness to license the patent, the owner of the SEP must make this infringer a licence offer, which must meet FRAND terms and specify the licence fees and how they are calculated.

The patent infringer has an obligation to respond to this offer with the due care resulting from the established practice in the relevant field and acting in good faith. Delaying tactics are forbidden. If he does not wish to accept the patentee's offer, he must make a counter offer within a short period, which in turn must correspond to FRAND terms. Should this counter offer be rejected, the infringer is also obliged to deposit adequate security in accordance with business practice in which also the infringer's billable number of past acts of use is considered. However, during the licence negotiations, the infringer is not prevented from attacking the legal validity of the patent in suit and/or from denying its usage and/or its essentiality for the implemented standard.

If the parties do not reach an agreement in this manner, the CJEU shall grant them the opportunity, by mutual consent, to have the licence terms determined by an independent third party, who has to decide within a short deadline.

Finally – according to the CJEU – the patent holder's possibility to sue the patent infringer for previous acts of infringement, requesting accounting and/or damages, is not affected by Article 102 TFEU.

The CJEU's chosen course thus strikes a balance between the owner-friendly Orange Book jurisprudence of the Bundesgerichtshof and the user-friendly Motorola decision of the European Commission dated April 29 2014 (C [2014] 2892).

stief.jpg
fuchs.jpg

Marco Stief

Stefan G Fuchs


Maiwald Patentanwalts GmbHElisenhof, Elisenstr 3D-80335, Munich, GermanyTel: +49 89 74 72 660 Fax: +49 89 77 64 24info@maiwald.euwww.maiwald.eu

more from across site and SHARED ros bottom lb

More from across our site

Licensing chief Patrik Hammarén also reveals that the company will rename its IPR business to better reflect its role in defining standards
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
News of Via Licensing Alliance launching its first semiconductor patent pool and INTA electing a new president were also among the top talking points
Submit your nominations to this year's WIBL Americas Awards by January 23
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
Gift this article